9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus–positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions-Reference-Cited by-同舟云学术

9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus–positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions

Published:2022-07-18 Issue:8 Volume:46 Page:1017-1024
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Shiraiwa Sawako,Kikuti Yara Yukie,Carreras Joaquim,Kondo Yusuke,Ohmachi Ken,Ogawa Yoshiaki,Kawada Hiroshi,Sato Shinji,Gion Yuka,Sato Yasuharu,Nakamura Naoya,Ando Kiyoshi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference25 articles.

1. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis;Kamel;N Engl J Med,1993

2. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate;Ellman;J Rheumatol,1991

3. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

4. Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population;Hashimoto;J Rheumatol,2015

5. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication;Hoshida;J Rheumatol,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunodeficiency-Associated Epstein-Barr Virus-Positive B-cell Lymphoproliferative Disorders;Surgical Pathology Clinics;2023-06

2. EBV-positive mucocutaneous ulcer arising in methotrexate-treated rheumatoid arthritis patients: a clinicopathological study of 12 cases with analysis of PD-L1 expression;Journal of Clinical and Experimental Hematopathology;2023